


MONTREAL, March 15 /CNW Telbec/ - Ranaz Corporation ("Ranaz") (TSXV: RNZ), a company specialized in the manufacturing and marketing of protein and dietary supplements, announces that it has granted a total of 1,700,000 stock options to directors and officers under its stock option plan, at an exercise price of $0.10 each. One third of the options will vest on each of the first, second and third anniversaries of the date of the grant. These options will expire on March 14, 2016.
About Ranaz Corporation
Ranaz is a corporation specializing in the manufacture and sale of protein and dietary supplements. Its mission is to create, develop and sell nutritional, protein and dietary supplements under its own corporate brands, such as "Protidiet" and "Protilife", as well as under private brands.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.